Cigarette smoking in living kidney donors: donor and recipient outcomes by Underwood, Patrick W. et al.
Cigarette smoking in living kidney donors:
donor and recipient outcomes
Underwood PW, Sheetz KH, Cron DC, Terjimanian MN, Englesbe
MJ, Waits SA. Cigarette smoking in living kidney donors: donor and
recipient outcomes.
Abstract: Background: Living kidney donor pools are expanding with
the use of “medically complex” donors. Whether or not to include
cigarette smokers as living kidney donors remains unclear. The aim of
this study was to determine the relationship between donor smoking and
recipient outcomes. We hypothesized that donor smoking would increase
donor complications and decrease allograft and recipient survival over
time.
Methods: The charts of 602 living kidney donors and their recipients
were retrospectively reviewed. Kaplan–Meier survival analysis and Cox
modeling were used to assess the relationships between smoking and
recipient and allograft survival.
Results: No diﬀerence in postoperative complications was seen in
smoking versus non-smoking donors. Donor smoking at time of
evaluation did not signiﬁcantly decrease allograft survival (HR = 1.19,
p = 0.52), but recipient smoking at evaluation did reduce allograft
survival (HR = 1.74, p = 0.05). Both donor and recipient smoking
decreased recipient survival (HR = 1.93, p < 0.01 vs HR = 1.74,
p = 0.048).
Discussion: When controlled for donor and recipient factors, cigarette
smoking by living kidney donors signiﬁcantly reduced recipient survival.
This datum suggests that careful attention to smoking history is an
important clinical measure in which to counsel potential donors and
recipients. Policy eﬀorts to limit donors with a recent smoking history
should be balanced with the overall shortage of appropriate kidney
donors.
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Amidst a continuing rise in the number of patients
on the kidney transplant waitlist, living donor kid-
ney transplantation programs have expanded the
criteria for donation. By including elderly and
obese donors, centers have boosted the number of
acceptable donors and demonstrated satisfactory
outcomes (1–3). Despite the resources devoted to
studying these “medically complex” donors, little
work has been done to assess the risks associated
with donor cigarette smoking. As the transplant
community continues to expand the donor pool,
further investigation of these non-traditional
donors is needed.
It remains controversial whether active cigarette
smokers should be allowed to donate. A 2007 sur-
vey of 132 U.S. kidney transplant programs found
that 80% of programs have a smoking policy when
evaluating living donors. Thirty-ﬁve percent of
programs accept current smokers as living donors,
and 36% require donors to commit to quitting
before surgery (4). It is not surprising that the liter-
ature surrounding this issue is unclear. A single-
center study of 100 patients demonstrated that
recipients of smoking donors had less improve-
ment in long-term postoperative creatinine and
glomerular ﬁltration rate when compared to non-
smoking donors (5). While the recommendation of
smoking cessation in kidney transplant recipients
is intuitive, inclusion of smokers as potential living
donors requires more investigation.
This study is a single-institution retrospective
analysis of live donor kidney transplants. We
hypothesize that donor smoking will be associated
with increased donor complications, decreased
recipient allograft survival, and decreased recipient
survival.
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Methods
Study population
This study was approved by the University of
Michigan Institutional Review Board. The charts
of patients aged 18 and older who acted as living
kidney donors between January 2000 and Febru-
ary 2008 and their recipients were retrospectively
reviewed. Age, race, gender, height, weight, BMI,
history of smoking, pack-years, and smoking sta-
tus at evaluation were collected for both donor
and recipient. Patients without a record of smoking
history in their charts were excluded from the
study. Smokeless tobacco and recreational drugs
were not included as a positive smoking history.
The primary exposure variable was tobacco use at
donor or recipient evaluation.
Survival
Cox modeling was used to assess the relationship
between donor smoking status at evaluation and
both overall graft recipient survival. The primary
outcome for graft survival was time to graft failure.
Patients were censored for death with functioning
graft or loss of follow-up. For recipient survival,
the primary outcome measured was time to death.
Patients were censored for earliest time of graft
loss or loss of follow-up.
Statistical analysis
Descriptive statistics were computed for the study
cohort. Continuous variables were summarized
by mean and standard deviation. Categorical
variables were summarized as percentages.
A stepwise backward elimination was used on all
candidate variables to create a subset of adjust-
ment covariates. All statistical computations were
performed in SPSS v17.0 (IBM Corp., Armonk,
NY, USA). A two-sided signiﬁcance level of a =
0.05 was used for analyses.
Results
Demographics
Overall, 156 (26%) of the 602 living donors were
smoking at the time of evaluation. Overall, there
were few clinically signiﬁcant diﬀerences between
donors who smoked and those who did not smoke
(Table 1). The average age of a kidney donor who
was smoking at evaluation was 38.0  10.2 yr
compared with 42.2  11.1 yr for non-smoking
donors (p < 0.01). There were more male smoking
donors compared with non-smoking donors
(46.1% male vs 37.2% male, p = 0.04). Donor
BMI was similar for both smoking donors and
non-smoking donors (27.2  4.8 vs 27.5  7.2,
p = 0.56).
The average age of the recipient was insigniﬁcant
between smoking donors and non-smoking donors
(46  13.8 year vs. 47.4  13.3 year, p = 0.27).
Diﬀerences between recipient sexes were also
insigniﬁcant for smoking donors and non-smoking
donors (64.7% male vs 57.8% male, 0.13).
Recipient BMI was similar in smoking donors
compared with non-smoking donors (28.6  6.2 vs
27.8  7.6, p = 0.19).
Donor complications
Diﬀerences between postoperative complications
were insigniﬁcant between smoking and non-
smoking donors (Table 2). The most common
complication was ileus at 6.73% in non-smoking
donors and 5.13% in smoking donors. Surgical
site infection, urinary retention, and urinary tract
infection (UTI) were other common complications
with rates under 5%.
Table 1. Donor and recipient demographics: graft loss and death
are reported as unadjusted values
Characteristic
Smoking
donor
Non-smoking
donor p-Value
N 156 446
Recipient age 46.0 (13.9) 47.4 (13.3) 0.27
Recipient sex (male) 64.7% 57.8% 0.13
Recipient race (white) 84.6% 82.1% 0.47
Recipient height (cm) 173.0 (10.0) 171.8 (11.2) 0.21
Recipient weight (kg) 85.8 (20.8) 82.0 (21.0) 0.051
Recipient BMI 28.6 (6.2) 27.8 (7.6) 0.19
Donor age 38.0 (10.2) 42.2 (11.2) <0.0001
Donor sex (male) 46.1% 37.2% 0.04
Donor race (white) 83.3% 82.5% 0.82
Donor height (cm) 170.7 (10.2) 169.3 (11.1) 0.15
Donor weight (kg) 79.4 (16.4) 78.6 (16.1) 0.60
Donor BMI 27.2 (4.8) 27.5 (7.2) 0.56
Recipient graft loss 23/156 (14.7) 62/446 (13.9) 0.06
Recipient death 46/156 (29.4) 88/446 (19.7) <0.01
Table 2. Donor complications by smoking history
Complication
Smoking
donor (%)
Non-smoking
donor (%) p-Value
SSI 4.49 2.47 0.20
Ileus 5.13 6.73 0.50
UTI 1.92 1.57 0.77
Urinary retention 1.92 3.81 0.26
Hernia 0 0.90 0.24
Other 10.26 10.09 0.95
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Graft survival
Donor smoking did not signiﬁcantly aﬀect recipi-
ent graft survival (HR = 1.19, 95%CI: 0.71–1.97,
p = 0.515; Fig. 1). Allograft recipients who were
smokers at the time of evaluation had lower rates
of graft survival than recipients who were not
smoking at the time of evaluation (HR = 1.74,
95%CI: 1.00–3.04, p = 0.05).
Recipient survival
Recipients of a kidney from a donor who smoked
at the time of evaluation also had lower overall
survival rates when compared to recipients who
received a kidney from a non-smoking donor
(HR = 1.93, 95%CI: 1.27–2.94, p = 0.002; Fig. 2).
Similarly, living kidney donor recipients who
smoked at the time of evaluation had signiﬁcantly
lower survival rates compared with recipients who
were not smoking at the time of evaluation
(HR = 1.74, 95%CI: 1.01–3.00, p = 0.048).
Discussion
A signiﬁcant proportion of kidney donors have an
active smoking history. We know little about how
actively smoking at the time of kidney donation
aﬀects donor and recipient outcomes. With this
study, we compare donor and recipient outcomes
from smoking and non-smoking living kidney
donors. We demonstrate that donor smoking does
not appear to be a signiﬁcant predictor of graft
survival but does appear to have some impact on
recipient survival. In addition, complications do not
appear to be more prevalent in the donors who
smoke. These data can be used as transplant centers
consider their living kidney donor smoking policy.
Not surprisingly, tobacco smoke has harmful
eﬀects on transplanted kidneys. Several studies
have investigated the eﬀects of cigarette smoking
in kidney transplantation. Recipient smoking has
been shown to signiﬁcantly decrease allograft and
recipient survival while cessation prior to trans-
plant can be beneﬁcial (6–8). A large study examin-
ing 45 307 deceased donor kidney transplants from
1994 to 1999 found a moderate, statistically signiﬁ-
cant eﬀect on graft and recipient survival (9). The
literature surrounding living donor smoking is
much less clear. To date, no studies have consid-
ered whether living kidney donor smoking aﬀects
graft and recipient survival.
As we expand criteria for living donation, we
must carefully consider donor risk. Within this
context, the modest eﬀect on recipient survival
may not provide enough evidence to preclude
living kidney donors who smoke. Nonetheless, the
transplant community should provide access to
resources for smoking cessation. This may help
improve the health of both the donor and
recipient.
Our analysis has several limitations. As this was
a retrospective single-institution study, the general-
izability may be limited. Further multi-institutional
studies would be required to corroborate these
ﬁndings. In addition, a more granular smoking
history at the time of donation including duration
of tobacco use, pack-years, and smoking cessation
prior to nephrectomy would be helpful for further
elucidation of causal mechanisms. Despite previ-
ous work that has isolated donor smoking as a risk
factor for graft loss in deceased donors, the quality
of allograft from living donors is superior, and the
observed eﬀect on allograft survival may be
insigniﬁcant. As many kidney donors are related to
the recipient, second-hand smoking exposure may
Fig. 1. Death-censored graft survival in living donor kidney
recipients from smoking and non-smoking donors. There was
no signiﬁcant diﬀerence between allograft survival between the
two cohorts (p = 0.52).
Fig. 2. Recipient survival in living donor kidney recipients
from smoking and non-smoking donors. Donor smoking sig-
niﬁcantly reduced recipient survival (p < 0.01).
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contribute the decreased survival in these recipi-
ents. Although a trend toward decreased allograft
survival was observed, greater numbers would be
needed to reach statistical signiﬁcance.
The outcomes of this study suggest that trans-
plant providers should be mindful of the risks
when evaluating potential living kidney donors
who smoke. Donors who are smoking at the time
of evaluation should be informed of the increased
risks and oﬀered access to smoking cessation
resources. Although this paper suggests an associa-
tion with worse outcomes, more work needs to be
done to establish a concrete relationship between
living kidney donor smoking and recipient out-
comes.
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